Who owns TRAVERE THERAPEUTICS INC?
- CUSIP Number: 89422g907
Tip: Access positions for across all investors
Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Travere Therapeutics stock
Who bought or sold TRAVERE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Simplex Trading | 203k | $7.8M | -2% | Dec 2025 |
|
| Hrt Financial | 121k | $3.6M | 100% | Mar 2026 |
|
| IMC-Chicago | 48k | $1.4M | -56% | Mar 2026 |
|
| Group One Trading | 40k | $1.2M | -67% | Mar 2026 |
|
Who sold out of Travere Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Sep 2025 | 445k | $11M |
| Exome Asset Management | Sep 2025 | 110k | $2.6M |